Literature DB >> 4451810

The effects of indomethacin and eicosa-5,8,11,14-tetraynoic acid on the response of the rabbit portal vein to electrical stimulation.

R Greenberg.   

Abstract

1 The effects of indomethacin and eicosa-5,8,11,14-tetraynoic acid (ETYA) on the contractile response of the transmurally stimulated rabbit portal vein were studied in vitro.2 When the veins were stimulated for 240 pulses at 1 and 2 Hz, the responses were potentiated by indomethacin and ETYA. However, responses to 4 and 8 Hz were not potentiated. The responses to continuous electrical stimulation at 2 Hz were also potentiated by indomethacin and ETYA. This potentiating effect was attenuated when the veins were pretreated with alpha-methyl-p-tyrosine. The responses of the veins to noradrenaline were not altered by either indomethacin or ETYA.3 Prostaglandin E(2) inhibited the responses of the portal vein to electrical stimulation. The magnitude of this inhibition was inversely related to the frequency of stimulation. The responses of the vein to noradrenaline were not altered by prostaglandin E(2).4 It is concluded that potentiation by indomethacin and ETYA of the response of the isolated portal vein is due to an increased release of newly synthesized noradrenaline as a result of inhibition of prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451810      PMCID: PMC1776927          DOI: 10.1111/j.1476-5381.1974.tb09687.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Antagonism by calcium of the inhibitory action of prostaglandin E2 on sympathetic neurotransmission in the cat spleen.

Authors:  P Hedqvist
Journal:  Acta Physiol Scand       Date:  1970-10

2.  Control by prostaglandin E2 of sympathetic neurotrans-mission in the spleen.

Authors:  P Hedqvist
Journal:  Life Sci       Date:  1970-03-01       Impact factor: 5.037

3.  Inhibition by prostaglandin E2 of sympathetic neurotransmission in the rabbit heart.

Authors:  P Hedqvist; L Stjärne; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1970-05

4.  Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation.

Authors:  I J Kopin; G R Breese; K R Krauss; V K Weise
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

5.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

6.  Preferential secretion of newly formed noradrenaline in the perfused rabbit heart.

Authors:  L Stjärne; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1970-11

7.  Inhibition by prostaglandin E1 of noradrenaline release and of effector response to nerve stimulation in the cat spleen.

Authors:  P Hedqvist; J Brundin
Journal:  Life Sci       Date:  1969-04-01       Impact factor: 5.037

8.  Inhibitors of purified beef adrenal tyrosine hydroxylase.

Authors:  S Udenfriend; P Zaltzman-Nirenberg; T Nagatsu
Journal:  Biochem Pharmacol       Date:  1965-05       Impact factor: 5.858

9.  Inhibition of prostaglandin biosynthesis by eicosa-5,8,11,14-tetraynoic acid.

Authors:  D G Ahern; D T Downing
Journal:  Biochim Biophys Acta       Date:  1970-09-08

10.  Roth RH: Influence of sympathetic nerve stimulation on conversion of H3-tyrosine to H3-catecholamine and on H3-norepinephrine disposition in rabbit pulmonary artery.

Authors:  A Kupferman; C N Gillis
Journal:  J Pharmacol Exp Ther       Date:  1970-02       Impact factor: 4.030

View more
  2 in total

1.  Indomethacin potentiation of the response of the rabbit portal vein to electrical stimulation: effect of stimulus frequency and train length.

Authors:  R Greenberg
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

2.  The neuronal origin of prostaglandin released from the rabbit portal vein in response to electrical stimulation.

Authors:  R Greenberg
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.